Neurodegenerative disorders are challenging to diagnose and monitor because the central nervous system is hard to access. To help patients, scientists hunt for noninvasive biomarkers of neuropathies. Neurofilament light (NF-L) is a biomarker for axonal damage in a number of disorders, including Alzheimer’s disease, Huntington’s disease, and multiple sclerosis, and is present in the blood, albeit at very low levels. Scientists rely on an automated microfluidic immunoassay to accurately measure this promising biomarker in patient blood samples.
Download this application note from ProteinSimple, a Bio-Techne brand, to learn how scientists measure a biomarker of neurodegeneration in patient blood.
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.